All India Organisation of Chemists and Druggists (AIOCD)’s call for a 24-hour nationwide ‘Pharma Bandh’ on May 20, 2026.

Date:

Share post:

On May 20, 2026, the local pharmacies that serve as the first point of care for millions of Indian families will go dark. The All India Organisation of Chemists and Druggists (AIOCD) has announced a 24-hour nationwide ‘Pharma Bandh’ to protect the future of the traditional “mom-and-pop” medical store.

For decades, the neighborhood chemist has been more than a shopkeeper; they are a trusted face in the community. Today, that relationship is under threat. The AIOCD is protesting the rise of unregulated e-pharmacies and corporate giants using “predatory pricing” to drive local stores out of business. “This isn’t just about profit; it’s about people,” says the AIOCD. “When a digital platform delivers medicine with a click, the human oversight of a qualified pharmacist is lost. We are seeing a dangerous rise in self-medication and the delivery of habit-forming drugs without proper prescriptions. We cannot trade public safety for corporate convenience.”

The AIOCD is calling on the government to withdraw notifications that favor online players over the 12.40 lakh small traders who form the backbone of India’s medicine distribution.

While shops will remain closed from midnight to midnight, pharmacists urge the public to stock up on essential medicines in advance. Emergency services at hospital-linked pharmacies will remain available to ensure no patient is left in a life-threatening situation.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...